Table 1 Variables from the questionnaire of the HBSC study analyzed in this study
Inhibitor | Target | Highest concentration |
|---|---|---|
Pistop2 | CME | 5 μM (GCRV 104); 25 μM (GCRV JX01) |
CPZ | CME | 10 μM (GCRV 104; GCRV JX01) |
Nystatin | Caveola-dependent endocytosis | 15 μM (GCRV 104) |
Methyl-β-cyclodextrin | Caveola-dependent endocytosis | 1 mM (GCRV 104) |
Dynasore | Dynamin | 10 μM (GCRV 104) |
Wortmannin | PI3K | 5 μM (GCRV 104) |
IPA-3 | Pak1 | 20 μM (GCRV 104) |
Rottlerin | PKC | 10 μM (GCRV 104) |
NH4Cl | PH | 20 mM (GCRV 104) |
Amiloride | NHE | 10 μM (GCRV 104) |
Bafilomycin A1 | Vacuolar ATPas inhibition | 2 nM (GCRV 104) |
Nocodazole | Microtubules | 10 μM (GCRV 104) |
Latrunculin B | Actin microfilaments | 0.5 μM (GCRV 104) |